The Root System — A Complete Guide to Insulin Resistance

Part Five: Treatment, Reversibility, and the Message of Hope

Your fasting glucose came back elevated. Your doctor ordered an HbA1c. There may have been a prescription, a dietary handout, a follow-up scheduled in three months. That encounter while not wrong, was insufficient for the scale of what you are dealing with.

Photo Courtesy of NIH Image Gallery

Parts One through Four of this series gave you the mechanism. This last piece gives you what you can do about it.

Remission Is Real — and It Is Not a Cure

Remission from insulin resistance and type 2 diabetes means sustained normal metabolic function without pharmacotherapy. It is documented in randomized controlled trials. The DiRECT trial, published in The Lancet Diabetes & Endocrinology, found that approximately 36% of participants in an intensive lifestyle intervention maintained full T2DM remission at two years, without medication, through weight loss and ectopic fat reduction (Lean et al., 2019).

Continued remission requires commitment to lifelong maintenance of lifestyle changes. Remission and even reversibility are possible for most people, but the degree of reversibility is dictated by the amount of residual insulin secretory reserve at the time of intervention. The earlier in the process you choose to act the higher the chances of remission, or even full reversal, success.

Early diagnosis with aggressive intervention becomes the best strategy for anyone with risks factors such as: abnormal fasting glucose, obesity, arterial hypertension, elevated triglycerides and low HDL cholesterol levels.

The Lifestyle Disease Framing

Insulin resistance is, for most of us, a lifestyle disease. The initial triggering events are closely linked to sedentary lifestyle, excessive calorie consumption and a diet rich in ultra-processed foods (UPF). All of these are part of a lifestyle conducive to metabolic dysregulation and mostly within our control.

Personal agency is the literal mechanism of treatment. The changes that produced the disease are the changes that can reverse it, the power to change the trajectory is all yours.

The food environment you have been living in was specifically engineered to override satiety signaling. The built environment was designed for sedentary efficiency. Education to understand the connection of lifestyle with the medical consequences never happened.

Dietary Intervention — Principles Over Prescriptions

The Mediterranean, DASH, and Volumetric diets are evidence-validated frameworks to address metabolic dysregulation. The principles they share include more intake of vegetables, whole foods, protein, with less ultra-processed food, and refined carbohydrate. You do not need to abandon your food culture just to understand the basic principles and how to apply them to your life.

The full framework for sustainable dietary change is developed in You Don’t Need a Diet Plan, which you can find in the archive.

Ultra-processed food reduction is the single most impactful dietary shift available. A well-designed inpatient randomized controlled trial by Hall et al. (2019), published in Cell Metabolism, found that participants on an ultra-processed diet consumed approximately 500 additional kilocalories per day compared to those eating minimally processed food with identical macronutrient availability under ad libitum conditions.

Ultra-processed foods are intentionally engineered to override the satiety signaling that would otherwise regulate intake. Remove them, and appetite regulation partially restores itself. The label reading skills that help you identify ultra-processed food are covered in Do You Know The One Part of the Food Label That Actually Matters? A dedicated post on ultra-processed food is forthcoming.

Eating sequence is a zero-cost intervention with documented effect. Consuming protein and vegetables before starches at a mixed meal reduces postprandial glucose peak by approximately 29–37% and postprandial insulin by approximately 20–48% compared to carbohydrate-first consumption, with no change in what you eat (Shukla et al., 2015; Shukla et al., 2017). This is developed in full in You Don’t Need a Diet Plan.

Protein-rich breakfast addresses multiple problems simultaneously. The cortisol peak of the morning creates a glucose-permissive hormonal environment that amplifies the postprandial insulin response to a carbohydrate-heavy breakfast. Adding protein blunts that response, produces sustained satiety through the morning, and supports muscle protein synthesis during the anabolic window following overnight catabolism. It simultaneously serves postprandial glucose management and sarcopenia prevention.

The all too common American breakfast pattern — a high calorie, carbohydrate rich meal, or worse yet, no breakfast at all — is the worst way to start your day. Without fiber or protein to slow down gastric emptying or stimulate satiety mechanism, they lead to excess calorie intake, a large glucose / insulin post-prandial peak with rapid disposal of the carbohydrate load. This typically leads to the mid-morning crash usually addressed by consumption of even more carbohydrate rich snacks as a bridge to lunch.

Start adopting a good balanced breakfast with high quality proteins instead of a heavy carbohydrate load.

The Supplement Landscape

Supplement claims are not required to be proven before products reach market. The FDA does not evaluate supplements for efficacy, or even safety, before sale. When you see a claim on a label, there is no regulatory requirement that it be true.

The two questions that cut through the marketing: What does the evidence actually show? And what is the effect size compared to sustained lifestyle change? On that second question, no supplement currently available produces metabolic improvements matching while sustained lifestyle modification achieves.

The best-supported supplements are just useful adjuvants, not the magic solution for bad habits.

If you enjoy evidence-based medical information, subscribe to receive these articles delivered to your mailbox every week.

Supplements with Genuine, Though Modest, Evidence

Berberine activates AMPK, the same energy-sensing enzyme activated by exercise and metformin, and produces modest but statistically significant glucose-lowering in multiple randomized controlled trials in T2DM and metabolic syndrome populations (Yin et al., 2008). The effect is very real but also modest, different from what social media currently claims.

The comparison between berberine and GLP-1 receptor agonists that circulates widely online is a misrepresentation. GLP-1 agonists operate through a completely different mechanism. Calling berberine “nature’s Ozempic” is like calling a bicycle “nature’s airplane” because both move you forward. The comparison is false.

Berberine is a potent inhibitor of CYP3A4, CYP2D6, and P-glycoprotein (Feng et al., 2019; Guo et al., 2012). These are the metabolic pathways responsible for clearing statins, warfarin, cyclosporine, certain antiarrhythmics, and certain antidepressants from your body. Inhibiting these pathways raises blood concentrations of those drugs, potentially to toxic levels. If you are on any prescription medication, you must discuss berberine with your physician before starting it.

Coenzyme Q10 (CoQ10) is an endogenous mitochondrial electron carrier whose synthesis shares the mevalonate pathway with cholesterol. Statin therapy inhibits that pathway, reducing CoQ10 synthesis. Mitochondrial CoQ10 depletion is linked to statin-associated muscle inflammation (Littarru & Langsjoen, 2007). For the insulin-resistant patient on statin therapy this creates a specific and legitimate reason to discuss CoQ10 with your physician. Modest independent evidence also supports modest reductions in fasting glucose and HbA1c with CoQ10 supplementation in T2DM populations (Moradi et al., 2018). Safety profile is favorable.

Myo-inositol functions as an insulin signaling second messenger. The strongest evidence is in PCOS and PCOS-spectrum presentations. It is a reasonable adjuvant for female insulin-resistant patients with hyperandrogenic features. Evidence outside this population is thinner.

Omega-3 fatty acids produce clinically meaningful triglyceride reduction at 2–4 grams of combined EPA/DHA daily, which is relevant because hypertriglyceridemia is common in insulin-resistant populations and carries independent cardiovascular risk. Food-first is preferable: fatty fish two to three times weekly. Supplementation is appropriate where dietary intake is consistently insufficient.

Magnesium is a cofactor for insulin receptor signaling, and deficiency is widespread in Western populations eating low whole-food diets. Replacement in deficient individuals is clinically indicated, with modest but consistent associations between magnesium status and insulin sensitivity (Barbagallo & Dominguez, 2015). Two points that must be stated clearly: first, confirm with your physician before starting over-the-counter supplementation, you may already be on replacement. Second, request serum magnesium measurement be included in your routine laboratory testing, it is inexpensive, widely available, and infrequently ordered without a specific request. Magnesium toxicity at excessive doses is real and should not be self-managed without monitoring.

Vitamin D deficiency is very common, and consistent associations between deficiency and insulin resistance are documented across multiple study designs (Pittas et al., 2007). Correcting documented deficiency is indicated but the same caveats as with magnesium: confirm existing replacement before supplementing, and request measurement during routine testing. Vitamin D toxicity carries serious medical risk including kidney stones, vascular calcification, and cardiac arrhythmia. Self-directed supplementation without documented deficiency and without monitoring is not advisable.

Popular Claims With Weak or Absent Evidence

Green tea and EGCG. The claim that green tea melts visceral fat is patently untrue. No meaningful clinical evidence supports significant visceral fat reduction or insulin resistance improvement at realistic intake levels. There is a genuine benefit available through substitution: replacing sweetened beverages, energy drinks, or high-calorie coffee preparations with unsweetened green tea removes a substantial daily glucose-fructose load.

Apple cider vinegar. Acetic acid produces a real, small, and vastly overstated reduction in postprandial glucose through gastric emptying delay. Claims in popular media exceed the evidence by an order of magnitude. Marginal value as a behavioral substitution.

Cinnamon. Small, inconsistent trials. Effect sizes do not reach clinical significance in better-designed studies. It adds great flavor, sprinkle it on when eating oatmeal, no significant benefit beyond that.

Thermogenic and metabolism-boosting supplements are among the worse class of dietary products requiring a clear a warning. The insulin-resistant population carries high background prevalence of hypertension, cardiac arrhythmia, and established cardiovascular disease. Many thermogenic supplements contain caffeine doses substantially exceeding a standard coffee serving, frequently combined with synephrine or yohimbine whose cardiovascular effects are additive. Hypertensive crisis, serious arrhythmia, atrial fibrillation, and acute cardiac events are well documented consequences of caffeine excess in cardiovascularly compromised patients (Palatini et al., 2009; Vlachopoulos et al., 2005). Read the label. If a supplement contains more caffeine than you would knowingly consume from coffee, do not take it without discussing it with your physician first. Better yet, don’t take it at all!

Detox and cleanse protocols have no mechanistic basis and no clinical evidence. Your liver and kidneys perform continuous detoxification without supplementation, provided they are functioning. This is not a category that warrants individual evaluation.

Pharmacological Intervention

Metformin remains the foundational pharmacological agent in insulin resistance and T2DM management, the most thoroughly validated, most affordable, and aligned with root pathophysiology. AMPK activation and suppression of hepatic glucose output are its primary mechanisms of action. Its long-term safety record is unmatched by any agent.

It is a treatment, not a cure: it manages the condition while taken and loses effect on discontinuation. For patients whose degree of insulin resistance warrants pharmacological support alongside lifestyle change, metformin is frequently appropriate and valuable along side lifestyle change.

GLP-1 receptor agonists represent the most significant pharmacological development in metabolic medicine in a generation. The cardiovascular, renal, and hepatic outcome data are real. The mechanism and the full clinical evidence base are covered in The GLP-1 Miracle Parts One and Two, which you can find in the archive. These are lifelong treatments, not cures. The STEP-4 withdrawal trial found that the majority of weight lost during GLP-1 agonist therapy is regained within one year of discontinuation, with metabolic parameters deteriorating correspondingly. The drug manages the condition does not resolve the root cause.

Pharmacotherapy and lifestyle changes are not competing options, they are complementary medical interventions. Medication as a bridge to the lifestyle change is a valid clinical strategy. Reduction or elimination of pharmacological dependence is achievable with sustained lifestyle changes.

Exercise Is an Insulin Sensitizer

Exercise is not primarily a caloric expenditure tool, is an insulin sensitizer one. Contracting skeletal muscle activates AMPK, which drives GLUT4 glucose transporter translocation to the cell surface through a pathway that is completely independent of insulin (Richter & Hargreaves, 2013). Muscle is taking up glucose directly, without requiring insulin to open the door. Simultaneously, exercise drives mitochondrial biogenesis, reduces muscle lipid accumulation, and promotes anti-inflammatory myokine secretion from contracting muscle.

Post-meal walking is the single most accessible metabolic intervention available. DiPietro et al. (2013) found that three 15-minute bouts of moderate post-meal walking reduced 24-hour glucose excursions more effectively than a single 30-minute morning walk in older adults at risk for impaired glucose tolerance. The mechanism is the AMPK-GLUT4 pathway described above, timed to intercept the postprandial glucose peak at its source. Accessible to any ambulatory person, implementable today. Ten minutes is a reasonable starting point; 15 minutes is what the evidence supports.

Incidental movement matters independently of structured exercise. Walking to nearby destinations, taking stairs, standing during phone calls accumulate meaningful metabolic benefit across the day. The independent metabolic risk of prolonged sitting is established and operates separately from how much formal exercise you do. It is not only how much you exercise but how much you move throughout the entire day.

Resistance training is the most important long-term metabolic investment available. Every kilogram of skeletal muscle preserved is glucose disposal capacity protected from the sarcopenia-insulin resistance feedback loop established in Part Two. Simple bodyweight resistance exercise at home performed consistently is enough for muscle preservation. Some examples include:

• Push-ups, pull-ups, chin-ups

• Dips, squats, lunges

• Step-ups

• Glute bridges, hip thrusts, single-leg deadlift, calf raises

Two to three sessions weekly of moderate resistance work, produces measurable long-term metabolic benefit.

Consistency is the requirement, not intensity. The insulin-sensitizing effect of exercise diminishes within 48–72 hours, requiring consistent renewal. A sustainable modest program produces better metabolic outcomes than an ambitious program abandoned after six weeks.

Sleep and Stress Are Not Secondary Recommendations

Seven to nine hours of sleep is a metabolic requirement. The Van Cauter laboratory’s research establishing sleep’s role in glucose regulation and insulin sensitivity (cited in Part Two) applies directly here in the treatment context. Improving sleep quality and duration is a critical metabolic intervention. Adding a supplement while sleeping only five hours a night is investing in the wrong intervention.

Chronic HPA axis activation is a direct metabolic driver, it is therefore a direct treatment target. Stress reduction is a metabolic intervention operating through cortisol and sympathetic nervous system pathways that drive insulin resistance.

The specific modality matters less than consistency: mindfulness, structured breathing, physical activity, social connection, professional psychological support where indicated. The goal is deliberate, consistent reduction of chronic HPA axis activation by whatever means you can actually sustain.

Education as Treatment

An educated person makes better choices because they understand what their choices are doing to their biology.

Biology is not your enemy, is a rational system responding to the environment it was given. Change the environment and the system will respond.

Remission is documented and can be achieved without bariatric surgery, expensive pharmacotherapy, or a complete life transformation.

A 15-minute walk after dinner, eggs instead of cereal, vegetables before the pasta, olive oil, seven hours of sleep. These changes are within reach of most reader of this piece.

“I’ve failed over and over and over again in my life and that is why I succeed.”

— Michael Jordan

I hope this series has served to expand your understanding about the main metabolic mechanism at the root of many of the worst modern diseases, and encourage you to implement the needed changes for a healthier you.

Found this article useful? Share your thoughts. Join the conversation below.

---

Educational content on The Metabolic Archives is free, because medical information should be accessible to everyone. If you find value and want to support the work, a paid subscription is available and genuinely appreciated. Visit the About Page for additional information.

The Metabolic Archives is for educational and informational purposes only, and is not intended as medical advice, diagnosis, or treatment, and does not constitute a doctor-patient relationship. Do not adopt any recommendation discussed in any article or guides published here, make changes or abandon any prescribed medical treatment without prior consultation with your physician. Always seek the advice of your physician or other qualified health provider for any questions regarding your medical condition and recommended treatment options.

By reading this post, you acknowledge that you have read and agree to the Terms of Service of The Metabolic Archives, which govern all use of this content including restrictions on reproduction.

© 2026 The Metabolic Archives. All rights reserved.